CASP8 and cancer: This variant has been found to decrease CASP8 activity and apoptotic reactivity of T lymphocytes through the cancer cell ex vivo model [8], and the decreased CASP8 activity may lead to an alteration of normal programmed cell death and result in tumor susceptibility.